Cantel Medical's gross profit is $540M, below the Healthcare sector average of $63B.
Get informed when a big investor buys or sells
+ FollowAs of Apr 30, 2021
Trailing 12 months ending Apr 30, 2021
Cantel Medical (CMD) currently reports a gross profit of $540M as of April 2021. That compares with $450M in the prior-year period — up 19.9% year over year. That is below the Healthcare sector average of $63B. Use the charts on this page to explore Cantel Medical's gross profit history and peer comparisons.
Cantel Medical's gross profit increased from $450M to $540M — a 19.9% year-over-year increase (period ending April 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Cantel Medical's gross profit of $540M is lower than the Healthcare sector average of $63B. That is roughly 99.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
Cantel Medical reported $540M in gross profit as of April 2021. That compares with $450M in the prior-year period — up 19.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current gross profit of $540M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $63B. From there, open related valuation or income-statement pages for Cantel Medical, and consider following CMD for alerts when major investors trade the stock.